Trial · NCT02926937
Adverse events45
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 45
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 5 | 150 | |
| other | Diarrhoea | Gastrointestinal disorders | Sotagliflozin 400 mg | 9 | 142 | |
| other | Diarrhoea | Gastrointestinal disorders | Sotagliflozin 200 mg | 5 | 107 | |
| other | Urinary tract infection | Infections and infestations | Placebo | 7 | 150 | |
| other | Urinary tract infection | Infections and infestations | Sotagliflozin 400 mg | 8 | 142 | |
| other | Urinary tract infection | Infections and infestations | Sotagliflozin 200 mg | 3 | 107 | |
| other | Headache | Nervous system disorders | Placebo | 9 | 150 | |
| other | Headache | Nervous system disorders | Sotagliflozin 400 mg | 4 | 142 | |
| other | Headache | Nervous system disorders | Sotagliflozin 200 mg | 7 | 107 | |
| serious | Retinal detachment | Eye disorders | Placebo | 0 | 150 | |
| serious | Retinal detachment | Eye disorders | Sotagliflozin 400 mg | 1 | 142 | |
| serious | Retinal detachment | Eye disorders | Sotagliflozin 200 mg | 0 | 107 | |
| serious | Colitis | Gastrointestinal disorders | Placebo | 1 | 150 | |
| serious | Colitis | Gastrointestinal disorders | Sotagliflozin 400 mg | 0 | 142 | |
| serious | Colitis | Gastrointestinal disorders | Sotagliflozin 200 mg | 0 | 107 | |
| serious | Gastrooesophageal reflux disease | Gastrointestinal disorders | Placebo | 1 | 150 | |
| serious | Gastrooesophageal reflux disease | Gastrointestinal disorders | Sotagliflozin 400 mg | 0 | 142 | |
| serious | Gastrooesophageal reflux disease | Gastrointestinal disorders | Sotagliflozin 200 mg | 0 | 107 | |
| serious | Lower gastrointestinal haemorrhage | Gastrointestinal disorders | Placebo | 1 | 150 | |
| serious | Lower gastrointestinal haemorrhage | Gastrointestinal disorders | Sotagliflozin 400 mg | 0 | 142 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02926937/events